FindTrial
Sign In

A study to determine how much margin is to be given around the enlarged pelvic lymph nodes in cervical cancer patients treated with intensity modulated radiation therapy

â??Prospective study to quantify the expansion volumes around the involved pelvic lymph nodes for planning Simultaneous Integrated Boost in patients of cervical cancer undergoing pelvic Intensity Modulated Radiotherapyâ??

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2016/12/007600
Enrollment
20
Registered
2016-12-19
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- Cervical cancer

Interventions

None listed

Sponsors

PGIMER CHANDIGARH
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Biopsy proven cancer cervix FIGO stage IB- IIIB 2. Karnofsky Performance Status greater than 70 3. Patient fit for concurrent chemotherapy 4. PET-CT evidence of significant pelvic lymphadenopathy 5. Patientâ??s willingness to give informed consent

Exclusion criteria

Exclusion criteria: 1. post operated cases of cancer cervix

Design outcomes

Primary

MeasureTime frame
To determine the expansion margin to be given around the involved pelvic lymph nodes for planning simultaneous integrated boost in patients of cervical cancer undergoing pelvic intensity modulated radiotherapyTimepoint: 6 WEEKS—

Secondary

MeasureTime frame
NONETimepoint: NONE—

Countries

India

Contacts

Public ContactRaviteja Miriyala

PGIMER, CHANDIGARH

ravitejamiriyala@yahoo.com9781037527

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026